Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623) announces a share repurchase program. Under the program, the company will repurchase up to CNY 150 million worth of its ordinary A shares. The shares will be repurchased at a price not more than CNY 20 per share.

The repurchased shares will be cancelled if can not be used for employee stock ownership plan within 36 months after the completion of the share repurchase. The repurchases will be funded from the company's own funds. The program will be valid for a period of 6 months.